12:00 AM
Oct 11, 2010
 |  BC Week In Review  |  Company News  |  Deals

Ablynx, Boehringer Ingelheim deal

Ablynx will receive a €3 million ($4.1 million) milestone payment from Boehringer under a 2007 deal to use Ablynx's Nanobody technology to discover, develop and...

Read the full 101 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >